Summarized by Masters of Longevity from Swiss Biotech.
The firms will combine standardized human multi-organoid in‑chip models with untargeted multi‑omics analysis.
Key Takeaways
- Standardized multi‑organoid chips are analyzed by untargeted multi‑omics.
- The collaboration is intended to improve biomarker and mechanism discovery.
- Clinical efficacy from these preclinical models has not been established.
